Early and late outcome after CABG in patients with evolving myocardial infarction

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue 5, 1997, Pages 848-856

  Sergeant, Paul ^a   Blackstone, Eugene ^b   Meyns, Bart ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Kentucky   (United States)

Author keywords

Cardio pulmonary resuscitation; Coronary bypass surgery; Myocardial infarction; Parametric analysis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CORONARY ARTERY BYPASS GRAFT; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESUSCITATION; RISK FACTOR; ST SEGMENT; SURGICAL TECHNIQUE; SURVIVAL RATE; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CARDIOPULMONARY RESUSCITATION; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; REOPERATION; RISK FACTORS; SHOCK, CARDIOGENIC; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030910689     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(97)01169-X     Document Type: Article

References (25)

1. ACC/AHA Task Force Subcommittee on Coronary Artery Bypass Graft Surgery. Guidelines and indications for the coronary artery bypass graft operation. J Am Coll Cardiol 1991;17:543-89.
2. AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1: 1988;545-549.
3. Alonso D, Scheidt S, Post M, Killip T. Pathophysiology of Cardiogenic Shock: quantification of myocardial necrosis, clinical pathologic and electrocardiographic correlation. Circulation 1973;48: 588-596.
4. Bates E, Topol E. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. JACC 1991;(18)4:1077-1084.
5. Blackstone E, Naftel D, Turner M. The decomposition of time-varying hazards into phases, each incorporating a separate stream of concomittant information. J Am Stat Assoc 1986;81:615-624.
6. DeWood M, Spores J, Berg R, Kendall R, Grunwald R, Selinger S, Hensley G, Sutherland K, Shields J. Acute myocardial infarction: a decade of experience with surgical reperfusion in 701 patients. Circulation 68 (Suppl II) 1983;8-16.
7. Flameng W, Daenen W, Borgers M, Thoné F, Xhonneux R, Van de Water A, Van Belle. Cardioprotective effects of lidoflazine during 1 hour normothermic global ischemia. Circulation 1981;64:796-807.
8. Flameng W, Borgers M, Van der Vusse G, Demeyere R, Vandermeersch E, Thoné F, Suy R. Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting. J Thorac Cardiovasc Surg 1983;85:758-768.
9. Flameng W, Vanhaecke J, Sergeant P, Suy R. Emergency coronary bypass surgery. In: Tilsner V, Matthias F, editors. Gerinnungswirkzame Therapie beim Myokardinfarct. Proc XXVIII Hamburger Symp über Blutgerinnung Editiones Roche, 1985, pp 119-124.
10. Flameng W, Sergeant P, Vanhaecke J, Suy R. Emergency coronary bypass grafting for evolving myocardial infarction. Effects on infarct size and left ventricular function. J Thorac Cardiovasc Surg 1987;94 (1):124-131.
11. Flameng W, Sergeant P, Vanhaecke J, Suy R. Emergency aortocoronary bypass surgery: late effects on infarct size and ventricular function. Adv Cardiol 1988;36:195-201.
12. Gruppo Italiano per lo Studio della Streptochinasi nellÕInfarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
13. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction. Lancet 1988;2:349-360.
14. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
15. Kloner R, Ellis S, Lange R, Braunwald E. Studies on experimental coronary artery reperfusion: effects on infart size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation 1983;68:8-15.
16. Mees U, Sergeant P, Daenen W, Flameng W. Succes and failure of the hemopump: a critical analysis. In: Flameng, editor. Temporary Cardiac Assist with an Axial Pump System. Springer Verlag, 1991, pp 51-59.
17. Meyns B, Sergeant P, Daenen W, Flameng W. Left Ventricular Assistance with the transthoracic 24 F Hemopump for recovery of the failing heart. Ann Thorac Surg 1995;60:392-397.
18. O'Keefe J, Bailey W, Rutherford B, Hartzler G. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients. Am J Cardiol 1993;72:107G-115G.
19. Sergeant P, Flameng W, Vanhaecke J, Suy R. Time constraints in the emergency coronary bypass surgery for acute evolving myocardial infarction. J Cardiovasc Surg 1987;28:68-74.
20. Sergeant P, Lesaffre E, Flameng W, Suy R. Internal mammary artery: methods of use and their effect on survival after coronary bypass surgery. Eur J Cardio-thorac Surg 1990;4:72-78.
21. Sergeant P, Lesaffre E. The K.U. Leuven Coronary Surgery Data Base, a clinical research data base. In: Databases for Cardiology. Kluwer Academic, Amsterdam, 1990.
22. Sergeant P. Risks and Prediction of adverse events after coronary bypass grafting based on a single center experience. In: LŸscher T, Turina M, Braunwald E, editors. Coronary Artery Graft Disease, Spinger Verlag, 1994.
23. Vanhaecke J, Flameng W, Sergeant P, De Roo M, Holvoet G, Suy R, De Geest H. Emergency bypass surgery: late effects on size of infarction and ventricular function. Circulation 1985;72(Suppl II):179-184.
24. von Segesser L, Lehmann K, Turina M. Deleterious effects of shock in internal mammary artery anastomoses. Ann Thorac Surg 1989;47:575-579.
25. von Segesser L, Popp J, Amann F, Turina M. Surgical revascularization in acute myocardial infarction. Eur J Cardio-thorac Surg 1994;8:363-369.